Skip to main content

Table 3 Receptor expression data

From: Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets

 

HCC

CCC

Total no.

71

27

 mean IRS

0.41

3.50

 median IRS

0

3.0

 minimum/maximum IRS

0/6

0/8

 positive cases (n)a

2 [3%]

18 [67%]

SSTR2

  

 mean

0.53

1.16

 median

0

0.25

 minimum/maximum IRS

0/6

0/4

 positive cases (n)a

6 [8%]

8 [30%]

SSTR3

 mean

0.39

0.48

 median

0

0

 minium/maximum IRS

0/6

0/3

 positive cases (n)a

4 [6%]

0 [0%]

SSTR4

 mean

0.15

0.07

 median

0

0

 minium/maximum IRS

0/2

0/2

 positive cases (n)a

0 [0%]

0 [0%]

SSTR5

 mean

0.81

1.52

 median

0

1.00

 minium/maximum IRS

0/6

0/8

 positive cases (n)a

11 [15%]

3 [11%]

 cases with microvessel positivity (n)b

24 [34%]

12 [44%]

CXCR4

 mean

1.76

2.70

 median

1.25

3.00

 minium/maximum IRS

0/6

0/6

 positive cases (n)a

27 [38%]

16 [60%]

 cases with microvessel positivity (n)b

35 [50%]

15 [56%]

  1. HCC hepatocellular carcinoma, CCC cholangiocellular carcinoma, IRS Immunoreactive Score; apositivity for a receptor was adopted at an IRS value ≥3; btumors with ≥10% of the vessels being stained for the respective receptor were considered positive